Body mass index (BMI) is not a complete measure of metabolic health, and a high proportion of U.S. adults with normal BMI still have obesity, according to research being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
FDA pushes back decision on Zevra’s drug; Revance to raise $100M
Plus, news about Iovance Biotherapeutics, Nektar Therapeutics, Heidelberg Pharma, Vivoryon Therapeutics and Absci: FDA delays decision on Zevra Therapeutics’ rare disease drug: The FDA will
March 5, 2024